ASN
EVFM

Advisory Services Network’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Advisory Services Network’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-27
Closed -$1K – 3881
2020
Q3 		$1K Buy
+27
New +$1.17K ﹤0.01% 3496

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

Advisory Services Network's EVFM Position: Q4 2020 in Review

Advisory Services Network sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2020, closing a stake of 27 shares — an estimated $1K sold.

Advisory Services Network first reported a position in EVFM in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 93 funds tracked by Wall St. Rank hold EVFM as of Q4 2020.

  • Advisory Services Network reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Advisory Services Network sold 27 Evofem Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $1K.
  • Advisory Services Network first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Advisory Services Network's Evofem Biosciences, Inc. Common Stock position peaked at $1K in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2020.

Based on Advisory Services Network's 13F filing for Q4 2020, filed 9 Feb 2021.